Effectiveness of combination therapy of broadband light and intradermal injection of tranexamic acid in the treatment of chloasma
Journal of Cosmetic Dermatology · 2023
DOI: 10.1111/jocd.15632 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2023. Verfasst von Zou Jia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Aesthetic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Melanosis, Tranexamic Acid. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suzhou Science and Technology Development Project, The Hospital Research Fund, The Special Project of "Technological Innovation" Project of CNNC Medical Industry Co. Ltd.
Abstract (Originalsprache)
Objective
To investigate the efficacy and safety of broadband light (BBL) combined with intradermal injection of tranexamic acid for treating melasma.
Methods
120 women with melasma admitted to our hospital from January 2021 to April 2022 were randomly categorized into the following groups: control group, treated with 250 mg tranexamic acid given orally twice daily, except during menstruation; group I, treated with BBL (Sciton, Inc., USA) monthly; group II, received intradermal injections of tranexamic acid monthly; and group III, treated with BBL with intradermal injection of tranexamic acid monthly. Treatment in each group lasted three months. The MASI (Melasma Area Severity Index) and VISIA (Canfield VISIA Complexion Analysis) were used for evaluation.
Results
After treatment course, MASI scores and VISIA brown spot and red zone ranking improved in all four groups ( p < 0.05). The decrease in MASI scores and improvement rates of VISIA brown spot and red zone rankings were not significantly different among the control group, group I, and group II; however, the decreased MASI scores and improvement rates of VISIA brown spot and red zone rankings were significantly higher in group III than in the other three groups ( p < 0.05).
Conclusion
The effect of BBL combined with the intradermal injection of TA in the treatment of melasma is remarkable. This combination therapy can be an alternative and effective treatment for managing melasma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic and Aesthetic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Party and Administration Office, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Dermatology and Cosmetic Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China.
- Department of Plastic and Aesthetic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
ORCID-Profile: Lijun Wu
Förderung
- Suzhou Science and Technology Development Project
- The Hospital Research Fund
- The Special Project of "Technological Innovation" Project of CNNC Medical Industry Co. Ltd
Zitieren
APA
Jia, Z., Tian, K., Zhong, Y., Wang, X., Gao, S., Xu, W., Li, K., & Wu, L. (2023). Effectiveness of combination therapy of broadband light and intradermal injection of tranexamic acid in the treatment of chloasma. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.15632
Vancouver
Jia Z, Tian K, Zhong Y, Wang X, Gao S, Xu W, et al. Effectiveness of combination therapy of broadband light and intradermal injection of tranexamic acid in the treatment of chloasma. Journal of Cosmetic Dermatology. 2023. doi:10.1111/jocd.15632
BibTeX
@article{Jia2023,
author = {Jia, Zou and Tian, Kai and Zhong, Yuanyuan and Wang, Xiaoyun and Gao, Suyue and Xu, Wushuang and Li, Ke and Wu, Lijun},
title = {Effectiveness of combination therapy of broadband light and intradermal injection of tranexamic acid in the treatment of chloasma},
journal = {Journal of Cosmetic Dermatology},
year = {2023},
doi = {10.1111/jocd.15632}
}
EUVIMED